**Job Description** Our Company is a leading global biopharmaceutical company with over 125-year history of Inventing for Life with an inspiring mission to make discoveries that positively impact global healthcare. Our success is driven by putting patients first, operating with the highest integrity, and committing fully to our vision to make a difference in the lives of people globally. With our diverse pipeline of vaccines, biologics, small molecules, and newer modalities, we are at the forefront of research to advance the prevention and treatment of diseases such as cancer, cardiometabolic diseases, Alzheimer’s disease, eye diseases, and infectious diseases including HIV, Ebola and SARS-Cov2. Our Company's Research Laboratories’ nonclinical safety assessment group at the West Point, Pennsylvania site is seeking an anatomic pathologist to join a highly collaborative team of scientists (14 anatomic pathologists, 3 clinical pathologists, and approximately 40 exceptional technical staff), working at a GLP-compliant facility with state-of-the-art anatomic, molecular and clinical pathology laboratories. Our team works on a diverse and exciting pipeline, participating in a wide variety of GLP-toxicology study types, many of which are run in-house, in addition to early discovery and investigative studies. Pathologists at our company are integral members and leaders of collaborative cross functional scientific teams, addressing challenges from early discovery to late development. Our Company’s pathologists provide scientific leadership in the design and conduct of postmortem evaluation of studies and integrate the interpretation of postmortem data into the safety profile of drug candidates. Our Company's pathologists have diverse opportunities to learn and grow as professional scientists and drug developers through daily study related activities and collaborative works with diverse program development teams. **Key responsibilities for this scientific role include:** + Employ routine H&E evaluations and specialized techniques to characterize the safety profile of new drugs from nonclinical toxicology and investigative studies + Work independently to create and interpret data, determine the significance of postmortem results, review literature + Opportunity to serve as Program Pathologist, providing scientific input and oversight across studies from very early discovery to late-stage development, following molecules throughout their development cycle + Communicate with study teams on postmortem findings and participate in projects to elucidate mechanisms of toxicity. + Provide scientific and technical guidance to technical staff. + Utilize tools and applications available on-site, including: + A robust historical control slide archive + Transmission electron microscopy + Immunohistochemistry and _in situ_ hybridization + Qualitative and quantitative digital pathology + Our Company's pathologists have the opportunity to be mentored as nonclinical safety assessment leads on enterprise-level drug development teams: + Generating regulatory strategy + Overseeing the design and execution of nonclinical toxicology studies + Communicating with global regulatory agencies + Our Company's pathologists interact closely with each other, share slides and opinions, and help each other learn and grow **Required experience and skills:** + Ability to collaborate with diverse cross-functional teams + An opportunity mindset + Doctor of Veterinary Medicine (DVM) + ACVP or ECVP-board certification in anatomic pathology **Preferred experience and skills:** + Proficiency in evaluation and interpretation of toxicology studies + PhD in Toxicology, Pathology, or related discipline + Experience as a pathologist in biotech, pharma or CRO + Knowledge of drug discovery, development and regulatory processes, Current Employees apply HERE (https://wd5.myworkday.com/msd/d/task/1422$6687.htmld) Current Contingent Workers apply HERE (https://wd5.myworkday.com/msd/d/task/1422$4020.htmld) **US and Puerto Rico Residents Only:** Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here (https://survey.sogosurvey.com/r/aCdfqL) if you need an accommodation during the application or hiring process. We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit: EEOC Know Your Rights (https://www.eeoc.gov/sites/default/files/2022-10/22-088\_EEOC\_KnowYourRights\_10\_20.pdf) EEOC GINA Supplement​ Pay Transparency Nondiscrimination (https://www.dol.gov/sites/dolgov/files/OFCCP/pdf/pay-transp\_%20English\_formattedESQA508c.pdf) We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively. Learn more about your rights, including under California, Colorado and other US State Acts (https://www.msdprivacy.com/us/en/CCPA-notice/) **U.S. Hybrid Work Model** Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, Monday - Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence.This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as “remote”. **San Francisco Residents Only:** We will consider qualified applicants with arrest and conviction records for employment in compliance with the San Francisco Fair Chance Ordinance **Los Angeles Residents Only:** We will consider for employment all qualified applicants, including those with criminal histories, in a manner consistent with the requirements of applicable state and local laws, including the City of Los Angeles’ Fair Chance Initiative for Hiring Ordinance **Search Firm Representatives Please Read Carefully** Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails. **Employee Status:** Regular **Relocation:** Domestic **VISA Sponsorship:** No **Travel Requirements:** 10% **Flexible Work Arrangements:** Hybrid **Shift:** Not Indicated **Valid Driving License:** No **Hazardous Material(s):** N/A **Job Posting End Date:** 03/10/2025 ***A job posting is effective until 11:59:59PM on the day** **BEFORE** **the listed job posting end date. Please ensure you apply to a job posting no later than the day** **BEFORE** **the job posting end date.** **Requisition ID:** R334375